Instrument Inactif

Autres langues Theseus Pharmaceuticals, Inc.

Actions

THRX

US88369M1018

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Theseus Pharmaceuticals, Inc. Announces Board Resignations	14/02
Theseus Pharmaceuticals Announces Closing of Tender Offer	14/02
Theseus Pharmaceuticals, Inc.(NasdaqGS:THRX) dropped from NASDAQ Composite Index	14/02
Concentra Biosciences, LLC completed the acquisition of Theseus Pharmaceuticals, Inc..	14/02
Theseus Pharmaceuticals, Inc.(NasdaqGS:THRX) dropped from S&P TMI Index	08/02
Concentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus Pharmaceuticals	30/01
SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates DSKE, THRX, CONN	11/01
THESEUS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Theseus Pharmaceuticals, Inc. - THRX	31/12
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSKE, KRTX, THRX, CONN	27/12
Sector Update: Health Care Stocks Gain in Late Afternoon	22/12
THRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Theseus Pharmaceuticals, Inc. Is Fair to Shareholders	22/12
Sector Update: Health Care Stocks Higher Friday Afternoon	22/12
Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right	22/12
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSKE, KRTX, THRX	22/12
Shareholder Alert: Ademi LLP investigates whether Theseus Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Concentra	22/12
Sector Update: Health Care Stocks Mixed Premarket Friday	22/12
Theseus Pharmaceuticals to be Acquired by Concentra Biosciences; Shares Rise Pre-Bell	22/12
Theseus Pharmaceuticals, Inc. Announces Employment Termination of Timothy P. Clackson as Chief Executive Officer, Effective December 7, 2023	04/12
Theseus Pharmaceuticals, Inc. Announces Management Changes	04/12
Theseus Pharmaceuticals Receives Acquisition Offers From Foresite, OrbiMed, Concentra Biosciences	27/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Theseus Pharmaceuticals, Inc.

Actions

THRX

US88369M1018

Autres langues

Filtres